Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRAX · as of Jun 8, 2026
Key Statistics
Explore Praxis Precision Medicines, Inc. Data
prax stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 75.0%
The PRAX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $595.93, representing +137.66% upside from the current price of $250.75.
Competitors & Peers
prax competitorsPRAX
ACAD
AKRO
CNTA
CRNX
IMVTStock Performance
Full HistoryAbout Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates i…
what is praxis precision medicines, inc. · prax stock overview · praxis precision medicines, inc. company profile · who is praxis precision medicines, inc. ceo · prax NASDAQ · praxis precision medicines, inc. headquarters · praxis precision medicines, inc. business segments
About Stock Overview & Key Data
Praxis Precision Medicines, Inc. (PRAX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 16, 2020. As of the latest trading session, PRAX stock price is $250.75, with a market capitalization of $5.3B. The stock has returned +472.73% over the past 12 months and -13.51% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Praxis Precision Medicines, Inc. stock is Buy, with an average 12-month price target of $595.93. In fiscal year 2025, Praxis Precision Medicines, Inc. reported revenue of — and net income of -$303.3M. For detailed data — including Praxis Precision Medicines, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Praxis Precision Medicines, Inc. (PRAX) stock price is $250.75. The stock is traded on NASDAQ under the ticker symbol PRAX. The 52-week range is $37.19 – $366.52.